TCL Archive In Brief: NCI Figure Left unchanged By Carter; Pay Raise Puts further Squeeze On Institute Budget March 4, 1977
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
